Saved in:
Bibliographic Details
Main Authors: Tzeng, Yen-Dun Tony, Chiang, An-Jen, Li, Chia-Jung
Format: Artículo científico
Language:en
Published: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2026
Online Access:https://pubmed.ncbi.nlm.nih.gov/41724057/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266082221948928
author Tzeng, Yen-Dun Tony
Chiang, An-Jen
Li, Chia-Jung
author_facet Tzeng, Yen-Dun Tony
Chiang, An-Jen
Li, Chia-Jung
Tzeng, Yen-Dun Tony
Chiang, An-Jen
Li, Chia-Jung
collection PubMed - marine biology
contents Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung
format Artículo científico
id pubmed_41724057
institution PubMed
language en
publishDate 2026
publisher Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
record_format pubmed
spellingShingle Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy.
Tzeng, Yen-Dun Tony
Chiang, An-Jen
Li, Chia-Jung
Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy. Tzeng, Yen-Dun Tony Chiang, An-Jen Li, Chia-Jung
title Targeting GCN5-mediated ERK lactylation: A promising drug development frontier in cancer therapy.
url https://pubmed.ncbi.nlm.nih.gov/41724057/